Introduction
Orthodontic tooth movement is achieved by the remodelling of periodontal ligament and alveolar bone in response to mechanical loading ( Garlet et al. , 2008 ) . The transduction of mechanical forces to the cells triggers a biologic al response, which has been described as an aseptic in ammation because it is mediated by a variety of in ammatory cytokines ( Garlet et al. , 2007 ) .
Bone resorption and bone formation are parts of the remodelling process during orthodontic tooth movement. Bone is deposited on the alveolar wall on the tension side of the tooth with both heavy and light forces and the newly formed bone spicules follow the orientation of the periodontal  bre bundles. On the pressure side, with light forces, alveolar bone is resorbed directly by numerous osteoclasts in Howship ' s lacunae ( Meikle, 2006 ) . It has been shown that orthodontic tooth movement may be in uenced by general and local administration of pharmaceutical agents ( Ohkawa, 1982 ; Kalia et al. , 2004 ; Arias and Marquez-Orozco, 2006 ; de Carlos et al. , 2006 ; Bartzela et al. , 2009 ; Gonzales et al. , 2009 ) .
Potassium diclofenac is a potent non -steroidal antiin ammatory drug (NSAID ; Boolbol et al. , 1996 ; Taketo, 1998a , b ; Baek et al. , 2001 ) . NSAIDs inhibit the two isoforms of prostaglandin H synthase [cyclooxygenase SUMMARY The early phase of orthodontic tooth movement involves sterile acute infl ammation of the periodontal ligament in response to biomechanical forces. Anti-infl ammatories are pharmacologic agents used in medical and dentistry clinics. The aim of the study was to analyse the bone remodelling during orthodontic movement under non -steroidal and steroidal treatment. Male Wistar rats ( n = 90) were randomly divided into three groups: C (control), non-steroidal anti-infl ammatory drug ( NSAID ; potassium diclofenac) , and steroidal anti-infl ammatory drug ( SAID ; dexamethasone dissodium phosphate ). The animals of the C group received 0.9 per cent saline solution , the NSAID group received potassium diclofenac CATAFLAM® (5 mg/kg ), and the SAID group received dexamethasone dissodium phosphate DEXANIL® (2 mg/kg). Animals were sacrifi ced 3, 7 , or 14 days after placement of the orthodontic appliance. The upper fi rst molars were processed histologically; we quantifi ed the blood vessels, Howship lacunae , and osteoclast-like cells present on the tension and compression sides of the periodontal ligament. Bone formation was evaluated under polarized light microscopy; 4.5 Image Pro-Plus® software calculated the percentage of immature/mature collagen present. The results showed that, in 3 and 7 days, NSAID and SAID groups presented fewer blood vessels, Howship lacunae , and osteoclast-like cells when compared to the control group. On the 7th and 14th days, there was a lower percentage of mature collagen in the SAID group ( P < 0.001). These data demonstrate that potassium diclofenac and dexamethasone inhibit bone resorption during the initial period of orthodontic movement and that dexamethasone delays the collagen maturation process in established bone matrix.
(COX)], COX-1 and COX-2, the enzymes responsible for the formation of prostaglandins from arachidonic acid. COX-1 is expressed constitutively, while mitogens, tumour promoters, and growth factors regulate COX-2 expression ( Herschman, 1996 ) . The expression of COX-2 seems to increase angiogenesis ( Tsujii et al. , 1998 ) ; conversely, COX inhibitors can attenuate angiogenesis ( Jones et al. , 1999 ) .
Dexamethasone is a potent steroidal anti-in ammatory drug (SAID) and has been demonstrated to inhibit prostaglandin and leukotrienes release through phospholipase A 2 down regulation ( Fässler et al. , 1996 ; Luo et al. , 2003 ) and altered growth factors activity (e.g. transforming growth factor-β 1 ; Swanson et al. , 2006 ) . Similarly, the drug delays gastric ulcer repair ( Luo et al. , 2003 ) and decreases collagen synthesis in cutaneous wounds ( Reis et al. , 2008 ) .
NSAID treatment delayed bone repair ( Altman et al. , 1995 ; Simon et al. , 2002 ) , while the effect of glucocorticoids on the components of bone remains unclear. Pharoah and Heersche (1996) suggest that dexamethasone inhibits the formation of multinucleated osteoclasts. Hofbauer et al. (1999) and Swanson et al. (2006) report that dexamethasone increases osteoclastogenesis and stimulates bone resorption. The aim of this study was to characterize the effects of NSAID and SAID in bone remodelling due to orthodontic movement.
Materials and methods
The research was approved by the Ethics Committee for Animals of Ponti cal Catholic University of Paraná ( PUCPR ; # 69.07) according to the guiding principles outlined in the ' Care and Use of Animals ' . Ninety male Wistar rats, 12 weeks of age, from the vivarium of the PUCPR, with an average weight of 350 g, were initially divided into three equal groups: C (control), NSAID (potassium diclofenac) , and SAID (disodic phosphate dexamethasone ; 30 animals each). Each group was composed by three subgroups, according to euthanasia day. The animals were kept in metal cages (three rats to a cage), fed a powdered diet (to prevent fracture of the orthodontic apparatus) , and given water ad libitum. They were maintained on a 12/12 h ou r light/dark cycle at 20°C during the experimental period.
In the control group, the animals received 0.9 per cent saline solution daily; in the NSAID group, the rats received daily doses of 5 mg/kg potassium diclofenac (Cata am ®; Novartis Biociências, São Paulo-SP, Brazil ) intramuscularly via; and the SAID group received daily doses of 2 mg/kg dexamethasone dissodium phosphate (DEXANIL ®; Ducto Indústria Farmacêutica Ltda., Anápolis-GO, Brazil ), intramuscularly via ( Allen et al. , 1998 ) .
The orthodontic movement was produced by a nickeltitanium closed coil spring (G&H® Wire Company, Hanover, Germany) that applied a reciprocal force of 30 gF between the maxillary right  rst molar and maxillary central incisors, measured using a Dynamometer gauge (Dentaurum, number 1005004). The coil spring was inserted while the animal was sedated with intramuscular injection of 1.8 mg/kg ketamine (Vetanarcol ®; Konig, Avellaneda, Argentina) and 1.1 mg/kg xylazine (Rompun ®; Bayer, São Paulo, Brazil ).
Animals were sacri ced on the 3rd , 7th , or 14 day with an overdose of anaesthetic ; maxillae were immediately removed and  xed in 10 per cent neutral formalin for 72 hours. Specimens were decalci ed for approximately 12 weeks in a 4.13 per cent EDTA aqueous solution. Transversal cuts obtained from mesio buccal root of maxillary  rst molars (4 µ m thickness) were cut and stained. For each specimen, 16 cuts from the alveolar crest up to the apices were obtained, where 12 were stained with hematoxylineosin (HE) and 4 with picrosirius .
The histological study was performed by one operator, blinded to treatment allocation. Osteoclast-like cells, active Howship lacunae , and blood vessels were quanti ed under × 400 magni cation using a light microscope. The histologic al criterion used to identify the osteoclast-like cells was the presence of multinuclear and eosinophilic cells on the bone surface ( Arias and Marquez-Orozco, 2006 ) .
One area from each section was selected for the evaluation of bone neoformation. The molecular organization of collagen was examined using a Leica DM LP microscope (Leica Microsystems Inc., Wetzlar, Germany ; original magni cation × 100). Mature and immature collagen  brils were distinguished by the different colours of interference and the intensity of collagen birefringence. Against a black background, thick yellow -red  bres were mainly mature collagen, while  ne net-like green  brils were mainly immature collagen. An automatic image analysis system was used to measure the luminance area (SM and SI) and total area of the  eld (S) for mature and immature collagen  brils. The ratio (per cent) of the luminance area to the total area of the  eld, SM/S and SI/S, was calculated to represent the content of mature and immature collagen  brils, respectively.
The mean values obtained were analysed statistically. Kolmogorov -Smirnov and Levene tests evaluated treatment normality and homogeneity. For inter group comparisons, Kruskal -Wallis non-parametric multiple comparisons were used when the values were non-normal, with a level of signi cance at P < 0.05. When the values were normal and homogeneous, ANOVA/Tukey parametric comparison was used with a level of signi cance at P < 0.05.
Results

Days.
In the sections of these samples, we observed decreased area density of osteoclast-like cells, Howship lacunae , and blood vessels in the NSAID and SAID groups in comparison to the control group. For all variables, the SAID group demonstrated lower levels than the NSAID group, with statistically signi cant differences between these groups for Howship lacunae and blood vessels ( P < 0.05 ; Table 1 ) .
NSAID and SAID groups demonstrated a greater proportion of immature collagen than the control group did ( P < 0.001). There was also a statistically signi cant difference ( P < 0.05) between NSAID and SAID groups ( Table 2 ) .
7 Days. In the sections of these samples, we observed in comparison to the control group ( P < 0.001 ; Figure 1A ), a decrease in osteoclast-like cells and Howship lacunae among the NSAID ( Figure 1B ) and SAID ( Figure 1C ) groups. The SAID group displayed fewer blood vessels than the NSAID group ( P < 0.05 ; Table 1 ). In the SAID group, there was less mature collagen deposition than in the control and NSAID groups, with a statistically signi cant difference between the control and SAID groups ( P < 0.001 ; Table 2 ).
14 Days. In the sections of these samples, the SAID group demonstrated a higher capacity for inhibiting Howship lacunae and blood vessels than the NSAID group ( P < 0.01 and P < 0.001, respectively ; Table 1 ). In this period, signi cant difference from control ( P < 0.001 ; Figure 2A ) and from NSAID ( Figure 2B ; P < 0.05 ; Table 2 ) groups were observed in relation to SAID group, which still demonstrated a high percentage of immature collagen ( Figure 2C ). 
Discussion
Cytokines are essential for evoke subsequent biological events and bone remodelling to accommodate movement of the tooth ( Sari et al. , 2004 ) . According to Krishnan and Davidovitch (2006) , arachidonic acid metabolites play an important role in the bone remodelling process during orthodontic tooth movement. The arachidonic acid release is metabolized by A2 phospholipase via two distinct pathways -the cyclooxygenase pathway that produces prostaglandins and the lipooxygenase pathway that leads to the release of leucotrienes. Prostaglandins are associated with higher numbers of osteoclasts ( Lee et al. , 2006 ) , as well as stimulating osteoblastic differentiation ( Krishnan and Davidovitch, 2006 ) .
The role of cytokines and prostaglandins in periodontal remodelling has been previously documented. Saito et al. (1990) showed that the bone resorption of periodontal ligament cells was induced by prostaglandin E2 (PGE2) in vitro . Furthermore, local application of PGE2 to teeth under orthodontic forces resulted in increased tooth movement ( Koide et al. , 1995 ) at a cellular level. Proin ammatory cytokines [ e.g. tumour necrosis factor-α or interleukin-1 β ] induce the cyclooxygenase-mediated production of prostaglandins in endothelial cells ( Maier et al. , 1990 ).
It has been described that potassium diclofenac inhibits COX-1 and COX-2, the enzymes responsible for the formation of prostaglandins from arachidonic acid, while dexamethasone inhibits prostaglandin and leucotriene release through phospholipase A 2 down regulation ( Fässler et al. , 1996 ; Luo et al. , 2003 ) .
Our investigation suggests that prostaglandin inhibition by anti-in ammatory drugs triggers a cascade of events following the application of orthodontic force. We observed reduced numbers of osteoclast-like cells, Howship lacunae , and blood vessels throughout all periods studied in the NSAID and SAID groups. The in uence of NSAIDs on orthodontic movement is supported by de Carlos et al. (2006) , who evaluated that two local injections of potassium diclofenac (10 mg/kg) completely eliminated  rst molar movement in rats.
All variables examined were more inhibited in the SAID group as compared to the NSAID group. At 3 and 14 days, there was a statistically signi cant difference in the number of Howship lacunae, with P < 0.05 and P < 0.01, respectively.
At each time-point, we observed that blood vessels in the NSAID group were not inhibited as strongly as in the SAID group. Vascularity and permeability increased, resulting in the release of biomechanical signal molecules and osteoclast precursor migration ( Krishnan and Davidovitch, 2006 ) . Roberts and Harts eld (2004) af rm that new osteoblast precursors are recruited from the population of pericytes around periodontal ligament capillaries. We suggest that inhibiting blood vessels by dexamethasone until day 14, resulted in fewer osteoclast-like cells, reducing Howship lacunae number and consequently bone resorption.
When comparing scienti c studies in the literature, we observed that glucocorticoids may produce antagonistic Table 1 Mean, standard deviation (SD), and P values. C, control; NSAID, potassium diclofenac; SAID, dexamethasone.
Parameter Day C, mean ± SD NSAID, mean ± SD SAID, mean ± SD Inter group difference, P Cells-like osteoclasts 3 5.8 ± 1.55 1.9 ± 0.74 0.7 ± 0.95 *C × NSAID, ***C × SAID 7 16.9 ± 3.35 7.5 ± 2.95 5.2 ± 3.05 ***C × NSAID, ***C × SAID 14 3.3 ± 1.06 3.1 ± 1.45 2 ± 2.26 NS Howship lacunae 3 6.4 ± 1.98 3.2 ± 1.03 0 ± 0 **C × NSAID, ***C × SAID, *NSAID × SAID 7 17.8 ± 2.57 5.8 ± 3.73 4.7 ± 1.64 ***C × NSAID, ***C × SAID 14 3.9 ± 1.98 5.3 ± 1.95 2.1 ± 1.59 **NSAID × SAID Blood vessels 3 25 ± 3.02 14.7 ± 2.58 7.6 ± 1.5 *C × NSAID, ***C × SAID, *NSAID × SAID 7 7.1 ± 1.45 16.8 ± 3.01 3.7 ± 2.87 ***C × NSAID, *C × SAID, *NSAID × SAID 14 3.1 ± 1.98 14.7 ± 3.4 1.6 ± 2.17 *C × NSAID, * **NSAID × SAID NS, non -signi cant. Signi cant level * P < 0 . 05 , ** P < 0 . 01 , *** P < 0 . 001 . 4 of 5 effects upon bone resorption during tooth movement. Ashcraft et al. (1992) evaluated the effect of cortisone acetate on orthodontic movement in rabbits and observed a decrease in the mean incremental active tooth movement. Ong et al. (2000) observed lower tartrate-resistant acid phosphatase-positive cells on the compression side after prednisolone administration, while Hofbauer et al. (1999) and Swanson et al. (2006) af rm that corticosteroids stimulate in vitro bone resorption by osteoclast activity and/ or formation increased . Kalia et al. (2004) used methylprednisolone 8 mg/kg/day under chronic and acute treatment and observed different results between the groups. In the acute, it was observed reduction on resorption percentage, while in the chronic, the tooth movement rate increased, due to secondary hyperparathyroidism.
For Ong et al. (2000) , these differences may be explained by variations within the animal species studied, forces used to move teeth, duration of experiment, dosage, duration of drug administration, and potency of the steroid used. We aimed to analyse bone neoformation on the tension side by polarized microscopy. This method allows us to detect mature and immature collagen, as well as correlate the three-dimensional distribution of collagen  bres with a particular stage of bone formation. The collagen colour and birefringence vary according to polymerization degree, re ecting  bre age and diameter; the collagen is initially deposited as thin  brils that aggregate until they form larger  bres or bundles ( Garavello-Freitas et al. , 2003 ) .
At all time-points, the NSAID and SAID groups presented lower mature collagen deposition than the control group. At 3 and 14 days, the SAID group exhibited impaired The present study recommends further research into orthodontic tooth movement in patients receiving potassium diclofenac and dexamethasone administration. It has been proposed that clinical appointments should be scheduled with longer intervals as bone turnover will be delayed. In summary, this study demonstrated that in ammation is essential to orthodontic movement and the use of glucocorticoids in orthodontic patients may delay the bone remodelling process .
